Effect of Tegaserod on Orocecal Transit in Elderly Chronic Constipation Patients

PHASE4TerminatedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

July 31, 2006

Primary Completion Date

April 30, 2007

Study Completion Date

April 30, 2007

Conditions
Chronic Constipation
Interventions
DRUG

Tegaserod

Trial Locations (3)

19140

Temple University Hospital, Philadelphia

72117

Arkansas Gastroenterology, PA, North Little Rock

48109-0362

University of Michigan Medical Center, Ann Arbor

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Temple University

OTHER

collaborator

University of Michigan

OTHER

lead

Novartis

INDUSTRY

NCT00348634 - Effect of Tegaserod on Orocecal Transit in Elderly Chronic Constipation Patients | Biotech Hunter | Biotech Hunter